Late-onset neutropenia (LON) recur in a MS patient after the second cycle of ocrelizumab: a case report

Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab

(2020) Michael Auer et al.   Multiple Sclerosis and Related Disorders

Late-onset neutropenia following ocrelizumab therapy for multiple sclerosis

(2019) Bruce A. Cohen   NEUROLOGY

Late onset absolute neutropenia associated with ocrelizumab treatment in multiple sclerosis: A case report and review of the literature

(2019) Chiara Zanetta et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Rituximab associated late-onset neutropenia—a rheumatology case series and review of the literature

(2016) William E. Monaco et al.   CLINICAL RHEUMATOLOGY

Late-Onset Neutropenia After Rituximab Treatment

(2010) Ofir Wolach et al.   MEDICINE

Immunoglobulin G Fc Receptor FcγRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma

(2009) Wen-Kai Weng et al.   JOURNAL OF CLINICAL ONCOLOGY